Published: Wednesday, July 17, 2019
The American Herbal Products Association (AHPA) submitted extensive and specific policy recommendations on July 15 to the Food and Drug Administration (FDA) to support responsible dietary supplement innovation while preserving and strengthening FDA’s ability to efficiently and effectively protect the public from unsafe and unlawful products.
AHPA submitted these recommendations to FDA in response to an April 11, 2019 Federal Register notice soliciting interested parties' input on various issues related to responsible innovation in dietary supplements through written comments and a public meeting held May 16, 2019.
"These comments provide several suggestions that are consistent with the shared goals of consumers, FDA and the supplement industry to
facilitate responsible dietary supplement product innovation while continuing to efficiently and effectively protect the public from unsafe and unlawful products.," said AHPA President Michael McGuffin.
AHPA's recommendations to FDA include:
"AHPA strongly encourages FDA to seriously consider these recommendations in order to support responsible innovation in dietary supplements," McGuffin said.
2021 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.